o High flexibility and safety for filling of liquid pharmaceuticals
o Bosch expands its portfolio in syringe processing and pure water generation
o Consulting services help achieve high Overall Equipment Effectiveness
Bosch Packaging Technology is presenting two recent developments in its filling and sealing machines for liquid pharmaceuticals at Interpack 2011 in Düsseldorf. The technologies offer high flexibility and safety to help manufacturers achieve cost reductions and comply with industry regulations. The new ARF 1020 series is designed for the filling and closing of open and closed ampoules as well as injection vials and ensures high product quality. It also offers easy operation and an output of up to 120 products per minute. Bosch will also introduce the new MLF 4000 for filling and sealing injection and infusion bottles. It offers gentle transportation of containers and features 100-percent in-process weight control (IPC) for high quality assurance.
Bosch also offers a one-stop-shopping concept for syringe processing with the new RIL300 Rod Inserter and Labeler, a high-speed, integrated system that inserts plunger rods precisely into syringes after filling and applies labels for tracking. With a continuous product flow, it allows high production capacity of up to 300 syringes per minute while advanced controls ensure product quality and sterility.
A new pure water generation system expands and completes Bosch's portfolio in the pharmaceutical sector. With a modular structure and eleven available sizes, the system can be customized to the unique needs of each manufacturer. This allows pharmaceutical manufacturers to produce 400 to 16,500 liters of ultrapure water, both purified (PW) and highly purified (HPW), per hour.
Bosch will introduce two new machines in the capsule filling portfolio. The GKF 2500 with a micro dosing system is suitable for small amounts of products. The GKF 702 with minibowl allows the simulation of filling a process for scale up with very less product in fast time, this is a real benefit for drug development projects.
At Interpack, Bosch will also introduce its OEE (Overall Equipment Effectiveness) Consulting service to enhance productivity throughout the manufacturing process. Bosch specialists work closely with manufacturers of pharmaceuticals to optimize machine performance and maximize output by offering the expertise and technical know-how to suggest and implement system improvements.
Contact person for press inquiries:
phone: +41 58 674-7416
The Bosch division Packaging Technology, based in Waiblingen (Germany), is one of the leading suppliers in the field of packaging technology. In 16 countries worldwide it develops and produces complete systems in packaging and process technology for the pharmaceutical, confectionery and food industries. Customized system solutions complete the service package. Bosch Packaging Technology's sales and service teams operate worldwide. More information at www.boschpackaging.com.
The Bosch Group is a leading global supplier of technology and services. According to preliminary figures, some 283,500 associates generated sales of 47.3 billion euros in the areas of automotive and industrial technology, consumer goods, and building technology in fiscal 2010. The Bosch Group comprises Robert Bosch GmbH and its more than 300 subsidiaries and regional companies in over 60 countries. If its sales and service partners are included, then Bosch is represented in roughly 150 countries. This worldwide development, manufacturing, and sales network is the foundation for further growth. Bosch spent some four billion euros for research and development in 2010, and applied for over 3,800 patents worldwide. With all its products and services, Bosch enhances the quality of life by providing solutions which are both innovative and beneficial.
Bosch is celebrating its 125th anniversary in 2011. The company was set up in Stuttgart in 1886 by Robert Bosch (1861-1942) as a "Workshop for Precision Mechanics and Electrical Engineering." The special ownership structure of Robert Bosch GmbH guarantees the entrepreneurial freedom of the Bosch Group, making it possible for the company to plan over the long term and to undertake significant up-front investments in the safeguarding of its future. Ninety-two percent of the share capital of Robert Bosch GmbH is held by Robert Bosch Stiftung GmbH, a charitable foundation. The majority of voting rights are held by Robert Bosch Industrietreuhand KG, an industrial trust.The entrepreneurial ownership functions are carried out by the trust.The remaining shares are held by the Bosch family and by Robert Bosch GmbH.
Additional information can be accessed at www.bosch.com, www.bosch-press.com, and www.125.bosch.com.
27-31 Clerkenwell Close
London, United Kingdom EC1 R0AT
+44 (0) 20 7014 3505